Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 04, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.
December 02, 2025 17:36 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors of Telix, Freeport, and Primo Brands to Contact the Firm About their Rights Before Lead Plaintiff Deadlines

NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
December 01, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.
November 29, 2025 08:45 ET | Source: Faruqi & Faruqi LLP

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or...
November 28, 2025 11:44 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors of Telix Pharmaceuticals and Firefly Aerospace to Contact the Firm About their Rights Before Lead Plaintiff Deadlines

NEW YORK, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
November 20, 2025 16:57 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors of Telix, Freeport, and Primo Brands to Contact the Firm About their Rights Before Lead Plaintiff Deadlines

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
November 20, 2025 14:24 ET | Source: Faruqi & Faruqi LLP

TLX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or...
November 11, 2025 10:20 ET | Source: Bragar Eagel & Squire

TELIX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Telix Pharmaceuticals Limited and Encourages Investors to Contact the Firm

Defendants allegedly overstated Telix’s prostate cancer drug progress and supply chain strength, misleading investors about its prospects.
September 11, 2025 17:09 ET | Source: Bragar Eagel & Squire

TELIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Telix Pharmaceuticals Limited on Behalf of Telix Stockholders and Encourages Investors to Contact the Firm

Telix disclosed an SEC subpoena over disclosures on prostate cancer drugs; ADRs fell 10% to $14.58 on July 23, 2025.
September 04, 2025 07:43 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Is Investigating Agilon, Albany International, Fluor, and Telix and Encourages Investors to Contact the Firm

NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc....